Edition:
United Kingdom

Pharmaceuticals

Boiron Q3 revenue increases to 163.9‍​ million euros

Oct 19 (Reuters) - BOIRON SA ::Q3 REVENUE EUR 163.9‍​ MILLION VERSUS EUR 159.4 MILLION YEAR AGO.LEVEL OF ACTIVITY AND PROFITABILITY OF FY 2017 WILL DEPEND ON THE SEASONAL PATHOLOGY OF Q4.

4:46pm BST

Roche drugs chief says Ocrevus uptake to vary across countries

Oct 19 (Reuters) - Roche Holding Ag :CFO expects no impact from currencies on 2017 sales, core operating profit or eps.Drugs chief Dan O'Day says not 'pulling back' on impower 150 trial expectations, still awaiting data.Drugs chief O'Day says remains bullish for ACE910 for non-inhibitor haemophilia...

2:43pm BST

Arcturus Therapeutics to collaborate with Johnson & Johnson

Oct 19 (Reuters) - Johnson & Johnson :Arcturus Therapeutics announces strategic collaboration with Johnson & Johnson Innovation to discover and develop RNA medicines.‍arcturus Therapeutics says has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals...

12:00pm BST

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.